Erythrocyte Aggregation Rehabilitation System( ERS)
Products Description
● Designed by simulating the pulsed magnetic resonance principle
and combining extremely low-frequency electromagnetic induction technology and spatial electromagnetic field control technology.
● During therapy, it works in this way: Through array reorganization of multiple pulse emission sources, it emits extremely low-frequency PEMF to correct anomalous distribution of charges on the surfaces of erythrocyte membranes.
● Effectively improve erythrocytes' rolling and deformality functions,mitigate and even eliminate the aggregation status of erythrocytes.
●Improve erythrocytes' rolling and deformality functions.
● Prevent thrombotic disease causes by erythrocytic aggregation,such as cerebral stroke, acute myocardial infarction, coronary heart disease and pulmonary embolism.
ERS Functional Features
● Safe：Magnetic field frequency 0.1 - 30Hz,Magnetic field intensity less than 40uT.
● Noninvasive：Non-intrusive treatment,No damage to normal cells.
● Intelligent：Fully intelligent management and full-automatic intervention program,Self-adaptive combination.
● Non-radiative：Electromagnetic radiation is only 1/100000 of cellphone radiation.This complies with national standard.
Clinical Date Certificate
About Us
● Founded in 2011;
● Root in the field of biomedical science;
● Rely on the core technologies- the bioelectricity technology, the pulsed magnetic control technology and the electroencephalogram-driven control technology;
● Focus on the early screening of diseases as well as intervention and rehabilitation of chronic diseases;
● Be committed to the research, development and production of health management equipment of the full life cycle.
Product Application
We have perfect solution for international community health services,hospital physical examination center,hospital rehabilitation center,athlete training center,large enterprises ,disease control centre,health management center etc.,
Our Certificate
HSAP owns more than 31 national patent, 27 software copyright.
Our products have passed CE, FDA and CFDA certification.
Our factory has passed ISO13485, ISO9001 certification.
Production Market
HSAP products has distributed to more than 20 countires and regions, such as Germany, Greece, USA, Canada, Mexico, Turkey, India, South Korea, UAE, Indonesia and so on.
Hot Tags: devices to prevent coronary heart disease, China devices to prevent coronary heart disease manufacturers, suppliers, factory, blood cell clustering apparatus, red cell agglutination improvement system, blood cell adjustment apparatus, blood cell recovery system, erythrocyte aggregation treatment system, blood cell aggregation modification equipment
